Share-based Payment Arrangement, Expense in USD of BIOLASE, INC from 2010 to Q3 2024

Taxonomy & unit
us-gaap: USD
Description
Amount of expense for award under share-based payment arrangement. Excludes amount capitalized.
Summary
BIOLASE, INC quarterly/annual Share-based Payment Arrangement, Expense history and change rate from 2010 to Q3 2024.
  • BIOLASE, INC Share-based Payment Arrangement, Expense for the quarter ending 30 Sep 2024 was $51K, a 81.5% decline year-over-year.
  • BIOLASE, INC Share-based Payment Arrangement, Expense for the twelve months ending 30 Sep 2024 was $299K, a 82% decline year-over-year.
  • BIOLASE, INC annual Share-based Payment Arrangement, Expense for 2023 was $1.23M, a 46.5% decline from 2022.
  • BIOLASE, INC annual Share-based Payment Arrangement, Expense for 2022 was $2.3M, a 38.6% increase from 2021.
  • BIOLASE, INC annual Share-based Payment Arrangement, Expense for 2021 was $1.66M, a 50.7% decline from 2020.
Share-based Payment Arrangement, Expense, Trailing 12 Months (USD)
Share-based Payment Arrangement, Expense, Quarterly (USD)
Share-based Payment Arrangement, Expense, YoY Quarterly Change (%)
Share-based Payment Arrangement, Expense, Annual (USD)
Share-based Payment Arrangement, Expense, YoY Annual Change (%)

BIOLASE, INC Quarterly Share-based Payment Arrangement, Expense (USD)

Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed
Q3 2024 $299K $51K -$225K -81.5% 01 Jul 2024 30 Sep 2024 10-Q 07 Nov 2024
Q2 2024 $524K -$46K -$130K -155% 01 Apr 2024 30 Jun 2024 10-Q 08 Aug 2024
Q1 2024 $654K $113K -$578K -83.6% 01 Jan 2024 31 Mar 2024 10-Q 13 May 2024
Q4 2023 $1.23M $181K -$432K -70.5% 01 Oct 2023 31 Dec 2023 10-K 21 Mar 2024
Q3 2023 $1.66M $276K -$315K -53.3% 01 Jul 2023 30 Sep 2023 10-Q 07 Nov 2024
Q2 2023 $1.98M $84K -$806K -90.6% 01 Apr 2023 30 Jun 2023 10-Q 08 Aug 2024
Q1 2023 $2.79M $691K +$482K +231% 01 Jan 2023 31 Mar 2023 10-Q 13 May 2024
Q4 2022 $2.3M $613K +$437K +248% 01 Oct 2022 31 Dec 2022 10-K 21 Mar 2024
Q3 2022 $1.87M $591K +$399K +208% 01 Jul 2022 30 Sep 2022 10-Q 09 Nov 2023
Q2 2022 $1.47M $890K +$524K +143% 01 Apr 2022 30 Jun 2022 10-Q 10 Aug 2023
Q1 2022 $943K $209K -$719K -77.5% 01 Jan 2022 31 Mar 2022 10-Q 11 May 2023
Q4 2021 $1.66M $176K -$827K -82.5% 01 Oct 2021 31 Dec 2021 10-K 21 Mar 2024
Q3 2021 $2.49M $192K -$655K -77.3% 01 Jul 2021 30 Sep 2021 10-Q 10 Nov 2022
Q2 2021 $3.14M $366K -$435K -54.3% 01 Apr 2021 30 Jun 2021 10-Q 11 Aug 2022
Q1 2021 $3.58M $928K +$209K +29.1% 01 Jan 2021 31 Mar 2021 10-Q 12 May 2022
Q4 2020 $3.37M $1M +$235K +30.6% 01 Oct 2020 31 Dec 2020 10-K 28 Mar 2023
Q3 2020 $3.14M $847K +$77K +10% 01 Jul 2020 30 Sep 2020 10-Q 10 Nov 2021
Q2 2020 $3.06M $801K +$354K +79.2% 01 Apr 2020 30 Jun 2020 10-Q 13 Aug 2021
Q1 2020 $2.7M $719K -$38K -5.02% 01 Jan 2020 31 Mar 2020 10-Q 13 May 2021
Q4 2019 $2.74M $768K -$138K -15.2% 01 Oct 2019 31 Dec 2019 10-K 17 Mar 2022
Q3 2019 $2.88M $770K +$166K +27.5% 01 Jul 2019 30 Sep 2019 10-Q 13 Nov 2020
Q2 2019 $2.71M $447K -$110K -19.7% 01 Apr 2019 30 Jun 2019 10-Q 14 Aug 2020
Q1 2019 $2.82M $757K +$56K +7.99% 01 Jan 2019 31 Mar 2019 10-Q 08 May 2020
Q4 2018 $2.77M $906K +$303K +50.2% 01 Oct 2018 31 Dec 2018 10-K 31 Mar 2021
Q3 2018 $2.47M $604K +$140K +30.2% 01 Jul 2018 30 Sep 2018 10-Q 12 Nov 2019
Q2 2018 $2.33M $557K -$204K -26.8% 01 Apr 2018 30 Jun 2018 10-Q 09 Aug 2019
Q1 2018 $2.53M $701K +$322K +85% 01 Jan 2018 31 Mar 2018 10-Q 10 May 2019
Q4 2017 $2.21M $603K +$6K +1.01% 01 Oct 2017 31 Dec 2017 10-K 30 Mar 2020
Q3 2017 $2.2M $464K -$224K -32.6% 01 Jul 2017 30 Sep 2017 10-Q 14 Nov 2018
Q2 2017 $2.43M $761K -$185K -19.6% 01 Apr 2017 30 Jun 2017 10-Q 13 Aug 2018
Q1 2017 $2.61M $379K -$455K -54.6% 01 Jan 2017 31 Mar 2017 10-Q 04 May 2018
Q4 2016 $3.07M $597K -$497K -45.4% 01 Oct 2016 31 Dec 2016 10-K 08 Mar 2019
Q3 2016 $3.56M $688K +$67K +10.8% 01 Jul 2016 30 Sep 2016 10-Q 01 Nov 2017
Q2 2016 $3.5M $946K +$11K +1.18% 01 Apr 2016 30 Jun 2016 10-Q 07 Aug 2017
Q1 2016 $3.48M $834K +$134K +19.1% 01 Jan 2016 31 Mar 2016 10-Q 04 May 2017
Q4 2015 $3.35M $1.09M 01 Oct 2015 31 Dec 2015 10-K 14 Mar 2018
Q3 2015 $621K 01 Jul 2015 30 Sep 2015 10-Q 08 Nov 2016
Q2 2015 $935K +$659K +239% 01 Apr 2015 30 Jun 2015 10-Q 01 Aug 2016
Q1 2015 $700K +$390K +126% 01 Jan 2015 31 Mar 2015 10-Q 09 May 2016
Q2 2014 $1.45M $276K -$104K -27.4% 01 Apr 2014 30 Jun 2014 10-Q 07 Aug 2015
Q1 2014 $1.55M $310K -$58K -15.8% 01 Jan 2014 31 Mar 2014 10-Q 01 May 2015
Q4 2013 $1.61M $370K +$50K +15.6% 01 Oct 2013 31 Dec 2013 10-K 11 Mar 2016
Q3 2013 $1.56M $491K +$134K +37.5% 01 Jul 2013 30 Sep 2013 10-Q 12 Nov 2013
Q2 2013 $1.43M $380K +$40K +11.8% 01 Apr 2013 30 Jun 2013 10-Q 08 Aug 2014
Q1 2013 $1.39M $368K -$215K -36.9% 01 Jan 2013 31 Mar 2013 10-Q 12 May 2014
Q4 2012 $1.6M $320K 01 Oct 2012 31 Dec 2012 10-K 06 Mar 2015
Q3 2012 $357K +$33K +10.2% 01 Jul 2012 30 Sep 2012 10-Q 12 Nov 2013
Q2 2012 $340K -$116K -25.4% 01 Apr 2012 30 Jun 2012 10-Q 09 Aug 2013
Q1 2012 $583K 01 Jan 2012 31 Mar 2012 10-Q 10 May 2013
Q3 2011 $324K 01 Jul 2011 30 Sep 2011 10-Q 09 Nov 2012
Q2 2011 $456K 01 Apr 2011 30 Jun 2011 10-Q/A 06 Sep 2012

BIOLASE, INC Annual Share-based Payment Arrangement, Expense (USD)

Period Value YoY Chg Change % Start Date End Date Report Filed
2023 $1.23M -$1.07M -46.5% 01 Jan 2023 31 Dec 2023 10-K 21 Mar 2024
2022 $2.3M +$641K +38.6% 01 Jan 2022 31 Dec 2022 10-K 21 Mar 2024
2021 $1.66M -$1.71M -50.7% 01 Jan 2021 31 Dec 2021 10-K 21 Mar 2024
2020 $3.37M +$628K +22.9% 01 Jan 2020 31 Dec 2020 10-K 28 Mar 2023
2019 $2.74M -$26K -0.94% 01 Jan 2019 31 Dec 2019 10-K 17 Mar 2022
2018 $2.77M +$561K +25.4% 01 Jan 2018 31 Dec 2018 10-K 31 Mar 2021
2017 $2.21M -$858K -28% 01 Jan 2017 31 Dec 2017 10-K 30 Mar 2020
2016 $3.07M -$285K -8.51% 01 Jan 2016 31 Dec 2016 10-K 08 Mar 2019
2015 $3.35M +$2.12M +172% 01 Jan 2015 31 Dec 2015 10-K 14 Mar 2018
2014 $1.23M -$376K -23.4% 01 Jan 2014 31 Dec 2014 10-K 10 Mar 2017
2013 $1.61M +$9K +0.56% 01 Jan 2013 31 Dec 2013 10-K 11 Mar 2016
2012 $1.6M +$72K +4.71% 01 Jan 2012 31 Dec 2012 10-K 06 Mar 2015
2011 $1.53M +$801K +110% 01 Jan 2011 31 Dec 2011 10-K 17 Mar 2014
2010 $727K 01 Jan 2010 31 Dec 2010 10-K 15 Mar 2013
* An asterisk sign (*) next to the value indicates that the value is likely invalid.